Snapshot img

US Cannabis Market Size 2025-2029

The US cannabis market size is forecast to increase by USD 141.48 billion at a CAGR of 37.1% between 2024 and 2029.

The US cannabis market is experiencing significant growth, driven by the expanding millennial population in key markets and increasing investment in research and production of medical marijuana. This demographic shift, coupled with growing acceptance of cannabis for medicinal purposes, presents a substantial opportunity for market expansion. From soothing medical treatments to trendy recreational products, cannabis is weaving its way into the fabric of American life, transforming healthcare, leisure, and local economies. However, challenges persist, including accessibility issues and high prices associated with medical cannabis. These obstacles necessitate strategic planning and innovation from industry players to effectively cater to consumer needs and maintain competitiveness.
Companies seeking to capitalize on market opportunities must navigate these challenges, ensuring regulatory compliance and offering competitive pricing and accessibility solutions. By addressing these factors, businesses can effectively position themselves in the dynamic and evolving cannabis market landscape.

What will be the size of the US Cannabis Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The cannabis market in the US is experiencing significant market dynamics and trends, with various entities playing crucial roles. Environmental impact is a pressing concern, as the industry explores sustainable practices, such as water management and energy efficiency, to minimize its carbon footprint. Economic impact is substantial, with tax revenue generation and job creation being key drivers. Regulatory challenges persist, as legal frameworks evolve, addressing issues like intellectual property, data analytics, and drug abuse prevention. Product safety and consumer safety are paramount, with rigorous testing for addictive substances and contaminants. Yield optimization and nutrient solutions are essential for maximizing profits, while cannabis accessories, including dab rigs and vaporizers, cater to diverse consumer preferences.
Waste management and public health concerns are also critical, as the industry navigates the complexities of the legal framework, grey market, and public opinion. Social equity initiatives aim to address historical injustices and promote community impact. Trichome analysis and legalization debates continue, as the industry strives for product standardization and consumer trust. Regulatory compliance, product safety, and sustainability are essential for navigating the evolving cannabis market landscape.

How is this market segmented?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Derivative Type

  CBD
  THC
  Balanced THC and CBD


Product

  Medical
  Recreational


Source

  Marijuana
  Hemp


Cultivation Type

  Indoor Cultivation
  Outdoor Cultivation
  Greenhouse Cultivation


Distribution Channel

  Dispensaries
  Online


Geography

  North America

    US

By Derivative Type Insights

The cbd segment is estimated to witness significant growth during the forecast period.

The CBD segment in the US cannabis market is expected to remain dominant due to the federal legality of hemp-derived CBD oil. This trend is driven by relaxing government norms regarding CBD usage in most states and at the federal level. As of 2024, states like Georgia and Indiana allow hemp-derived CBD oil for medicinal purposes, with Georgia permitting oil containing up to 5% THC for specific medical conditions, and Indiana allowing its use as long as it contains less than 0.3% THC. Quality control and compliance regulations are crucial in the cannabis industry, with potency testing, heavy metal testing, microbial testing, and pesticide testing being essential for ensuring consumer safety.

Extraction methods, such as supercritical fluid extraction and CO2 extraction, play a significant role in the production of CBD isolate, broad-spectrum CBD, and THC oil. Brand development and marketing strategies are essential for businesses looking to succeed in the competitive cannabis market, with product labeling, inventory management, and consumer perception being key factors. The cannabis market encompasses various product offerings, including cannabis edibles, cannabis concentrates, and cannabis cultivation methods like soil cultivation, outdoor growing, and indoor growing. Organic cannabis and child-resistant packaging are also important considerations for businesses. Despite t

Licensed cannabis industry statistics, revenue, sales, expenses, inventories, investment, production, number of cannabis for medical use licenses issued, number of registered clients, shipments to registered clients, average amount of dried cannabis for medical use authorized per client, average amount of dried cannabis for medical use per client shipment, producer price, Canada, annual.

The global cannabis market size is projected to grow from USD 52.01 billion in 2025 to USD 290.73 billion by 2033, exhibiting a CAGR of 24%.
Report Scope:

The Cannabis Market Report is Segmented by Product Type (Flower, Pre-Rolls, Concentrates, and More), by Application (Medicinal, Adult-Use/Recreational, and More), by Compound Type (THC-Dominant, CBD-Dominant, and More), and by Geography (North America, Europe, Asia-Pacific, South America, Middle East, and Africa). The Market Forecasts are Provided in Terms of Value (USD).

This data set contains preliminary weekly retail sales data for cannabis and cannabis products in both the adult-use cannabis and medical marijuana markets. The data reported is compiled at specific points in time and only captures data current at the time the report is generated. The weekly data set captures retail cannabis sales from Sunday through Saturday of the week. Weeks spanning across two different months only include days within the same month. The first and last week of each month may show lower sales as they may not be made up of a full week (7 days). Data values may be updated and change over time as updates occur. Accordingly, weekly reported data may not exactly match annually reported data.

Data source: Cannabis Retail Sales by Week Ending

Image Source: Unsplash

By 2025, it is estimated that the state of California will have the highest share of the legal cannabis market in the United States, at a value of ** percent. Florida is estimated to have an ***** percent market share in 2025.

Cannabis market is expected to grow from USD 39.21 billion in 2024 to USD 47.76 billion in 2025 and USD 231.81 billion by 2035, representing a CAGR of 17.1%.

In the United States, sales of legal recreational cannabis are expected to reach nearly ** billion U.S. dollars by 2030. Legal marijuana sales are forecast to increase steadily with each consecutive year. Sales per state The number of cannabis consumers is likewise expected to grow in the United States: by 2025, the country is projected to have close to ** million consumers. In 2018, the state of California was by far the leading American state in terms of legal, as well as illicit cannabis sales. The market for recreational marijuana in California amounted to some *** billion U.S. dollars in 2018. This was more than double the market size of New York. By 2024, the recreational cannabis market in California is forecast to reach *** billion dollars. Opinions on legalization In 2020, more than ********** of adult Americans believed cannabis should be made legal in the United States. Over the past decades, public support for the legalization of the soft drug has increased significantly. In 2003, only about ******* of Americans were in favor of legalization, while more than ** percent of the population was against it.

In 2018, medical cannabis products were legalized for the first time in the United Kingdom. Subsequent to this legalization, the country's medical cannabis market is forecasted to increase in size massively. In 2023, the of medicinal cannabis market in the UK stood at *** million U.S. dollars, and by 2027 it is projected to exceed *** million U.S dollars.

The Medical Marijuana Market Report is Segmented by Formulation Type (Capsules, Oils, and More), Cannabinoid Composition (THC-Dominant, and More), Route of Administration (Oral, Inhalation, Sublingual, and More), Application (Chronic Pain, Arthritis, Migraine, and More), Distribution Channel (Hospital Pharmacies, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Snapshot img

Legal Cannabis Market Size 2025-2029

The legal cannabis market size is valued to increase USD 142.39 billion, at a CAGR of 31.7% from 2024 to 2029. Rising number of countries decriminalizing and legalizing cannabis will drive the legal cannabis market.

Major Market Trends & Insights

North America dominated the market and accounted for a 92% growth during the forecast period.
By Product - Medical cannabis segment was valued at USD 11.85 billion in 2023
By Derivative Type - CBD segment accounted for the largest market revenue share in 2023

Market Size & Forecast

Market Opportunities: USD 853.08 million
Market Future Opportunities: USD 142391.30 million
CAGR : 31.7%
North America: Largest market in 2023

Market Summary

The market represents a dynamic and rapidly evolving industry, fueled by the continuous decriminalization and legalization of cannabis in various parts of the world. According to recent reports, the number of countries permitting the use of cannabis for medicinal or recreational purposes has significantly increased, with some estimating that over 65% of the global population now resides in jurisdictions with lenient cannabis policies. This market expansion is driven by a growing recognition of the potential therapeutic benefits of cannabis, as well as shifting societal attitudes towards its use. In this evolving landscape, core technologies and applications, such as hydroponics, LED lighting, and automated cultivation systems, are revolutionizing cannabis production.
Service types and product categories, including cultivation, processing, and retail, are seeing significant investment and innovation. However, the industry faces challenges, such as limited funding and investment opportunities, which hinder its growth potential. Despite these hurdles, the market presents substantial opportunities for businesses and investors alike, offering a promising future in a continually unfolding market.
The impact environmental factors cannabis cultivation plays a crucial role in determining plant health and yield, while the effects light spectrum cannabinoid production influence the potency of harvested buds. Through optimization nutrient solutions hydroponic systems, growers can enhance growth and efficiency. The role microbial communities soil health cannabis cannot be understated, contributing to robust plant development. Implementing effectiveness integrated pest management strategies and methods improving cannabinoid potency cannabis plants ensures higher quality crops. Detailed analysis terpene profiles different cannabis strains and comparison various extraction methods cannabinoid yield help refine product offerings. Additionally, assessment post-harvest processing techniques shelf life, strategies enhancing water usage efficiency cannabis, and techniques optimizing energy consumption indoor cultivation support sustainable practices, while assessment quality control measures cannabis products guarantees consumer trust.

What will be the Size of the Legal Cannabis Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the Legal Cannabis Market Segmented and what are the key trends of market segmentation?

The legal cannabis industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product

  Medical cannabis
  Recreational cannabis


Derivative Type

  CBD
  THC
  Balanced THC and CBD


Source

  Hemp
  Marijuana


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    Australia
    China
    India
    Japan


  Rest of World (ROW)

By Product Insights

The medical cannabis segment is estimated to witness significant growth during the forecast period.

In the dynamic the market, various cultivation techniques are employed to optimize crop yields and improve product quality. Cloning propagation methods, such as asexual propagation, ensure consistency in plant genetics. Harvesting is optimized through crop rotation schedules, growth cycle management, and water usage efficiency. Energy consumption metrics are closely monitored to minimize environmental impact. Trichome development and genetic modification methods are essential for enhancing cannabinoid profiling and plant morphology. Organic cultivation practices, including seed germination techniques and soil health indicators, cater to consumer preferences. Terpene extraction methods, such as hydrocarbon extraction and phytochemistry analysis, contribute to the unique flavors and aromas of cannabis strains.

Environmental control systems, integrated pest management, and microbial community analysis ensure disease management and nutrient uptake efficien

Revenue for the US cannabis farming industry has expanded at a CAGR of 9.4% since 2020 to reach $19.7 billion in 2025, with a 6.0% increase in the year. This growth has been driven primarily by the continued expansion of legalized state markets, particularly the adoption of recreational use in new jurisdictions such as New York, Maryland and Minnesota. However, rapid maturation has led to imbalances in established markets like Colorado, Washington and California, where broad licensing and production surges have created excessive supply. Oversupply has caused wholesale prices to collapse, eroding profitability for growers and forcing widespread consolidation as smaller farms struggle to cover costs in a sharply competitive environment. Shifting consumer preferences are reshaping the market landscape as cannabis becomes increasingly integrated into lifestyle and wellness routines. National surveys indicate record levels of public support and expanding consumption, particularly among adults replacing alcohol with cannabis-based alternatives. Product innovation is at the center of this shift, with edibles, pre-rolls and vaping products expanding consumer engagement through convenience and discretion. At the same time, hemp-derived THC products have emerged as formidable competitors due to lighter regulation, lower prices and broad accessibility in traditional retail channels. These offerings are pulling demand from dispensaries and pressuring regulated producers to differentiate through quality, safety and branding. Looking ahead, the path of legalization will remain the most critical determinant of industry expansion. Additional state-level approvals and potential movement on stalled federal reforms could open new markets and investment flows, supporting revenue growth projected at a CAGR of 5.8% through 2030 to reach $26.1 billion. Yet the industry faces growing challenges from climate change, which threatens yields and adds cost volatility through drought, heat and pest pressure. To manage production risks and achieve efficiency, cultivators are increasingly adopting precision agriculture, hydroponics and climate-controlled systems. These technologies enhance sustainability and output reliability but require significant capital investment, meaning profitability over the outlook period will hinge on innovation, scale and resilience.

Colorado’s Department of Revenue publishes a range of data about the state’s legal marijuana industry, including spreadsheets of monthly sales totals and taxes collected by county and medical/retail status. Other states that have legalized recreational marijuana and publish downloadable, machine-readable sales data include California, Connecticut, Illinois, Maine, Massachusetts, New Mexico, Oregon, and Washington. Those with data in PDFs include Arizona, Maryland, Michigan, Montana, New Jersey, and Rhode Island

The size of the Medical Cannabis Market market was valued at USD 26.91 Million in 2023 and is projected to reach USD 85.87 Million by 2032, with an expected CAGR of 18.03% during the forecast period. Recent developments include: In March 2024, Jesse Ventura introduced a cannabis edible brand. Ventura partnered with Retro Bakery, based in Columbia Heights, to manufacture THC edibles derived from hemp., February 2023: Metrc reported the expansion of its contract with the State of Missouri to support the regulation of its adult-use cannabis market.. Key drivers for this market are: Increasing Number of Countries Legalizing the Use of Medical Marijuana, Trend of Producing Edible Products with Cannabis; Favorable Reimbursement Environment and Government Support in Certain Countries. Potential restraints include: Lack of Awareness about the Dosage and Medicinal Properties of Marijuana, Social Stigma Related to Cannabis Use. Notable trends are: The Chronic Pain Segment is Expected to Experience the Fast Growth Over the Forecast Period.

The North America, Europe & Asia Pacific Legal Cannabis Market is estimated to be valued at USD 36.2 billion in 2025 and is projected to reach USD 345.7 billion by 2035, registering a compound annual growth rate (CAGR) of 25.3% over the forecast period.

The global legal cannabis market is expected to grow in the forecast period of 2025-2034 at a CAGR of 23.00%.

Australia’s Medical Cannabis industry has experienced soaring growth and regulatory evolution since cannabis cultivation was legalised for medical purposes in 2016. Despite challenges relating to strict regulations and advertising restrictions, industry manufacturers have thrived, buoyed by the gradual societal acceptance of cannabis use. Industry revenue is expected to have skyrocketed at an annualised 78.1% over the five years through 2024-25, to $445.6 million. This includes an anticipated jump of 53.0% in 2024-25. Profit margins have remained negative, although losses are improving thanks to surging revenue and demand. In November 2021, revisions to regulations set out by the Therapeutic Goods Administration (TGA) led to a surge in prescriptions and improved patient access to medical cannabis treatments. These changes introduced five categories of approved product formats, simplifying the prescription process and enhancing efficiency for medical practitioners. Government initiatives – like making CBD products available over the counter and implementing a streamlined medicinal cannabis application process – have bolstered revenue for manufacturers. Greater investment in the Medical Research Future Fund (MRFF) and access to government grants have further supported the development of medical cannabis manufacturing. However, despite burgeoning sales and demand, imports have captured most demand, curtailing domestic production growth. As the industry matures, existing manufacturers are poised to benefit from economies of scale, while more international companies will enter the market through partnerships and acquisitions. Expanding demand and advances in medical cannabis technology will open up offshore opportunities, presenting substantial potential for Australian businesses to target export markets. However, the potential legalisation of recreational cannabis would present both opportunities and challenges for manufacturers. While medical cannabis users would likely stick with established manufacturers for their reliable and knowledge-based products, recreational legalisation could hinder demand from customers who don’t want to seek out a prescription. Industry manufacturers would have to carefully navigate this uncertainty and could consider expanding into the recreational market to capitalise on potential opportunities. Overall, industry revenue is forecast to soar at an annualised 11.4% over the five years through 2029-30, to $763.8 million.

Cannabis producers in Canada have blossomed in recent years as recreational products were legalized in 2018, opening up massive growth. Since Health Canada opened up medicinal cannabis production to more players in 2013, producers have grown continuously as they invest in production capabilities to produce quality products. As consumers shifted from illegal cannabis purchases to the licensed recreational market, cannabis growers have grown significantly, but revenue is expected to contract 1.0% in 2024 alone as the novelty of legal cannabis has worn off and most the black market has shifted to licensed purchases, which has decreased growth. Revenue has ballooned at a CAGR of 29.4% to reach $12.6 billion over the past five years. The Cannabis Act was passed in 2018, but ever since its announcement the industry has begun to shift and transform as it transitions into a full-blown consumer product industry. The medicinal marijuana market had been expanding quickly, particularly as it was the only legal cannabis market until late 2018. This has driven innovation and investment into the industry from the biggest producers, which has boosted the industry. The announcement of the legalization of recreational cannabis has shifted production and demand away from medicinal cannabis, which has driven up prices at a significantly faster rate, almost to match the price of recreational cannabis. This has also fomented growth as prices industry-wide have increased. Large capital investment and continued adaptation to a new market amid strong regulations and lack of expertise have also kept profit negative. The industry is still new, adapting to a new environment as established companies explore new frontiers and unlicensed producers transition into legality. Profit is expected to improve in the coming years as growers enhance efficiency and revenue continues to grow as demand continues to shift away from the illegal market. Despite this, the illegal market will likely remain a strong threat and may dampen revenue growth in the future. Competition is expected to intensify and cannabis producers will likely continue adjusting as they explore a new market. Revenue is expected to grow at a CAGR of 1.6% to $13.7 billion over the five years to 2029.

Cannabis production by industry and medical and non-medical use, Canada, provinces and territories, annual.

Snapshot img

Marijuana Market Size 2024-2028

The marijuana market size is forecast to increase by USD 87.8 billion, at a CAGR of 32.14% between 2023 and 2028.

Major Market Trends & Insights

North America dominated the market and accounted for a 87% growth during the forecast period.
By the Product - Medical marijuana segment was valued at USD 9.19 billion in 2022
By the Type - Oil and tinctures segment accounted for the largest market revenue share in 2022

Market Size & Forecast

Market Opportunities: USD 627.41 million
Market Future Opportunities: USD 87804.60 million
CAGR : 32.14%
North America: Largest market in 2022

Market Summary

The market continues to evolve, with significant shifts in consumer behavior and business strategies. According to recent studies, the global legal the market is projected to reach a value of USD73.6 billion by 2027, growing at a steady pace. This expansion is driven by increasing acceptance and legalization of marijuana for medicinal and recreational use in various regions. One notable trend is the growth of the e-commerce sector within the marijuana industry. In 2020, online sales of cannabis products in North America alone reached USD4.3 billion, representing a 45% increase from the previous year. This trend is expected to continue, as consumers increasingly turn to online platforms for convenience and safety during the ongoing pandemic. Moreover, the medical marijuana sector is witnessing significant advancements, with new product innovations and research studies highlighting its potential therapeutic benefits. For instance, a 2019 study published in the Journal of Pain found that medical cannabis significantly reduced opioid use among chronic pain patients. These findings underscore the potential of marijuana as a viable alternative to traditional pain management methods. In conclusion, the market is experiencing continuous growth and transformation, driven by increasing legalization, consumer preferences, and technological advancements. The e-commerce sector is gaining traction, while the medical marijuana industry is witnessing significant innovation and research. These trends are set to shape the future of the market, offering opportunities for businesses and investors alike.

What will be the Size of the Marijuana Market during the forecast period?

Explore market size, adoption trends, and growth potential for marijuana market Request Free SampleThe market continues to evolve, driven by advancements in various sectors. Two significant areas of innovation are trichome development and vaporization technology. Trichome development, a crucial aspect of cannabis cultivation, has seen improvements in understanding the role of environmental stress management and plant tissue analysis in optimizing potency and yield. In contrast, vaporization technology has gained traction due to its ability to preserve the plant's active compounds, leading to a more consistent user experience. Oil extraction techniques have also advanced, with yield estimation models and ph monitoring systems enhancing efficiency and quality. Meanwhile, pharmaceutical-grade cannabis production relies on stringent quality assurance protocols, ec monitoring systems, and disease resistance breeding to ensure consistent product purity and safety. These innovations contribute to the ongoing evolution of the market, with topical product development, edible product development, and infusion processes continuing to gain momentum.

How is this Marijuana Industry segmented?

The marijuana industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments. ProductMedical marijuanaRecreational marijuanaTypeOil and tincturesFlowerGeographyNorth AmericaUSCanadaEuropeGermanyUKAPACAustraliaRest of World (ROW)

By Product Insights

The medical marijuana segment is estimated to witness significant growth during the forecast period.

The market is experiencing significant expansion as medical marijuana gains traction as an alternative to conventional pain medications. Approximately 50 million Americans live with chronic pain, fueling market growth in countries like the US. Marijuana plants, such as Cannabis indica, Cannabis sativa, and hybrids, can alleviate various types of chronic pain, including neuropathic and inflammatory pain. Furthermore, medical marijuana offers potential relief for patients suffering from conditions causing severe nausea, including Crohn's disease, acute gastritis, hypoglycemia, panic disorder, and arachnoiditis. Sustainable cultivation methods, such as hydroponics and soil-less systems, are increasingly adopted to optimize yield and reduce water usage. Plant growth regulators, nutrient solution management, and climate control t